Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 94%.
- 3 different insiders bought in the last 90 days.
- Similar past buys beat the S&P 500 52% of the time (110 cases), above the 46% for all buys.
Reasons for caution
- Other insiders sold $45M in the same 90 days, more than was bought.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $250K–$1M · stock down 20%+ in 3 months
BCAB Jun 23, 2022 +189.1% vs S&PFCNCA Mar 13, 2023 +106.4% vs S&PPFSI Mar 20, 2020 +98.6% vs S&PMYO May 15, 2025 -77.0% vs S&PMITT Mar 12, 2020 -68.1% vs S&PANDE Mar 18, 2020 -55.5% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
W. Bryan Hill (a director) bought $554K of EQPT at about $13.85 on Nov 11, 2026, reported to the SEC on Nov 12, 2026. Buys like this beat the S&P 500 52% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the EQPT alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.